| European Case Law Identifier: | ECLI:EP:BA:2017:T104513.20171023 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 23 October 2017 | ||||||||
| Case number: | T 1045/13 | ||||||||
| Application number: | 03759693.9 | ||||||||
| IPC class: | A61K 31/44 A61K 38/18 A61P 25/24 |
||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | D | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | METHOD OF TREATMENT OF PSYCHOLOGICAL CONDITIONS BY ADMINISTRATION OF NERVE GROWTH FACTOR | ||||||||
| Applicant name: | Milkhaus Laboratory, Inc. | ||||||||
| Opponent name: | - | ||||||||
| Board: | 3.3.01 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Sufficiency of disclosure - support by the description (no) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t131045eu1.html
Date retrieved: 17 May 2021